Titterton Lewis H jr 4
4 · Anixa Biosciences Inc · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Titterton Lewis H jr
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-15$2.92/sh+16,000$46,720→ 969,334 total - Exercise/Conversion
Employee Stock Option
2025-12-15−16,000→ 0 totalExercise: $2.92From: 2016-02-18Exp: 2026-02-18→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]Right-To-Buy, pursuant to a stock option grant dated February 18, 2016.